Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer

Patients with immunodeficiencies and older age are at an increased risk of anal cancer. Transgenic <i>K14E6/E7</i> mice with established high-grade anal dysplasia were treated topically at the anus with the protease inhibitor saquinavir (SQV) in the setting of CD4+ T-cell depletion to mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Evan Yao, Laura Gunder, Tyra Moyer, Kristina A. Matkowskyj, Kathryn Fox, Yun Zhou, Sakura Haggerty, Hillary Johnson, Nathan Sherer, Evie Carchman
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/9/1421
Tags: Add Tag
No Tags, Be the first to tag this record!